GLP-1 boom disrupting diet market
The rise of GLP-1 drugs is changing how people approach healthy eating and weight management, impacting the $135 billion U.S. diet market U.S. Weight Loss Market Status & Forecast Report 2025-2026: GLP-1 Boom Triggers Major Industry Shift as Medicalized Programs Disrupt the $135 Billion Diet Market.
The GLP-1 boom is leading to a surge in medicalized weight loss programs, disrupting traditional diet plans and weight loss approaches. The U.S. weight loss market, currently valued at $135 billion, is facing a major shift as GLP-1 drugs gain popularity. This trend is expected to continue into 2025-2026. Companies in the diet and weight loss industry will need to adapt their strategies to incorporate medical options like GLP-1 drugs to stay competitive.
